Angiotensin-Converting Enzyme Inhibitor Therapy Effects in Patients With Heart Failure With Preserved and Mid-Range Ejection Fraction. [PDF]
Cardiol Res, 2021 Safonova J +9 more
europepmc +1 more source
How to Improve the Cardiac Function and Clinical Outcomes in Patients with Heart Failure with a Mid-range Ejection Fraction. [PDF]
Intern Med, 2021 Imamura T.
europepmc +1 more source
Safety and efficacy of sacubitril/valsartan vs. benazepril administered as initial treatment for STEMI patients with mid-range ejection fraction: a propensity score matching analysis. [PDF]
Front Cardiovasc MedWang Y +8 more
europepmc +1 more source
The Societal Burden of Heart Failure With Preserved or Mid-Range Ejection Fraction. [PDF]
JACC AdvWeintraub WS, Alva M.
europepmc +1 more source
Long-Term Outcomes of Heart Failure With Preserved or Mid-Range Ejection Fraction in the United States. [PDF]
JACC AdvSun LA +7 more
europepmc +1 more source
The impact of empagliflozin and metformin on cardiac parameters in patients with mid-range ejection fraction heart failure without diabetes. [PDF]
J Med LifeSabbar R +5 more
europepmc +1 more source
Trends in cause-specific readmissions in heart failure with preserved vs. reduced and mid-range ejection fraction. [PDF]
ESC Heart Fail, 2020 Cui X +5 more
europepmc +1 more source
Clinical Characteristics of Admitted Heart Failure Patients with Preserved Mid-Range and Reduced Ejection Fraction [PDF]
Background: Heart failure (HF) presents a serious burden in India, with estimated prevalence ranging from 1.3 to 4.6 per million populations. Heart failure risk factors are diverse and probably vary by geographical region.
Mouhamed Nazar K, Ponnambalam, K Suresh
core
Trajectories of Waist-to-Hip Ratio and Adverse Outcomes in Heart Failure with Mid-Range Ejection Fraction. [PDF]
Obes Facts, 2020 Gao F +5 more
europepmc +1 more source
Mortality from Heart Failure with Mid-Range Ejection Fraction. [PDF]
Arq Bras Cardiol, 2022 Dutra GP +6 more
europepmc +1 more source